North America still dominates the medical aesthetics market, with over 50% share. The US alone spends more on Botox and fillers than any other country. But Asia‑Pacific is the fastest‑growing region, driven by South Korea, Japan, and China. The medical aesthetics market forecast shows that Asia‑Pacific will grow at over 10% CAGR, because of rising disposable income and the influence of K‑beauty.

What's different? In Asia, the focus is on glass skin — luminous, even‑toned, poreless. That means laser toning, chemical peels, and skin boosters (microinjections of hyaluronic acid). The medical aesthetics market analysis highlights that men are a huge demographic in Asia — Seoul has more men getting Botox than anywhere else.

In North America, the focus is on anti‑aging and body contouring. Liposuction, tummy tucks, and breast augmentation are still big. But non‑invasive fat reduction (CoolSculpting, SculpSure) is taking over.

The takeaway: aesthetics is not one‑size‑fits‑all. What works in LA may not work in Shanghai. But the underlying trend is universal: people want to look like the best version of themselves.